RespireRx Pharmaceuticals Inc (fka RSPI)

[jerrydylan]

I think if someone like Baxter wanted to co-develop RD with us and fund a good bit of it we'd have a much higher stock, and eventually worth say at least $600-700 million pre-2009 pipes about $10 or so. I think they had SGP interested in RD as well, way back when in 2008 summer some interest in a pro-drug for RD combining cx-???? with Oxycontin or another pain drug. The effect of Ampakines on the RD opens up a whole cadre of things these drugs might do, yet here we are.